title: Properties of protein drug target classes.
abstract: Accurate identification of drug targets is a crucial part of any drug development program. We mined the human proteome to discover properties of proteins that may be important in determining their suitability for pharmaceutical modulation. Data was gathered concerning each protein's sequence, post-translational modifications, secondary structure, germline variants, expression profile and drug target status. The data was then analysed to determine features for which the target and non-target proteins had significantly different values. This analysis was repeated for subsets of the proteome consisting of all G-protein coupled receptors, ion channels, kinases and proteases, as well as proteins that are implicated in cancer. Machine learning was used to quantify the proteins in each dataset in terms of their potential to serve as a drug target. This was accomplished by first inducing a random forest that could distinguish between its targets and non-targets, and then using the random forest to quantify the drug target likeness of the non-targets. The properties that can best differentiate targets from non-targets were primarily those that are directly related to a protein's sequence (e.g. secondary structure). Germline variants, expression levels and interactions between proteins had minimal discriminative power. Overall, the best indicators of drug target likeness were found to be the proteins' hydrophobicities, in vivo half-lives, propensity for being membrane bound and the fraction of non-polar amino acids in their sequences. In terms of predicting potential targets, datasets of proteases, ion channels and cancer proteins were able to induce random forests that were highly capable of distinguishing between targets and non-targets. The non-target proteins predicted to be targets by these random forests comprise the set of the most suitable potential future drug targets, and should therefore be prioritised when building a drug development programme.
authors.affiliation: Manchester Institute of Biotechnology, Faculty of Life Sciences, The University of Manchester, 131 Princess Street, Manchester M1 7DN, United Kigndom.
authors.forename: Simon C
authors.initials: SC
authors.lastname: Bull
authors.affiliation: Manchester Institute of Biotechnology, Faculty of Life Sciences, The University of Manchester, 131 Princess Street, Manchester M1 7DN, United Kigndom.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Doig
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D019295:Computational Biology / Q000379:methods; D030562:Databases, Protein; D055808:Drug Discovery; D006801:Humans; D007473:Ion Channels; D058990:Molecular Targeted Therapy; D010447:Peptide Hydrolases; D010770:Phosphotransferases; D011506:Proteins / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000145:classification*; D043562:Receptors, G-Protein-Coupled
chemical_list: D000970:Antineoplastic Agents; D007473:Ion Channels; D011506:Proteins; D043562:Receptors, G-Protein-Coupled; D010770:Phosphotransferases; D010447:Peptide Hydrolases
references.citation: Nat Rev Cancer. 2004 Mar;4(3):177-83
references.pmid: 14993899
references.citation: Cancer Cell. 2002 Mar;1(2):117-23
references.pmid: 12086869
references.citation: Biophys J. 2010 Feb 3;98(3):396-403
references.pmid: 20141752
references.citation: Nat Rev Cancer. 2008 Mar;8(3):167-79
references.pmid: 18256617
references.citation: Nat Rev Drug Discov. 2011 Aug 01;10(8):579-90
references.pmid: 21804595
references.citation: BMC Bioinformatics. 2009 Dec 15;10:421
references.pmid: 20003500
references.citation: FASEB J. 1995 May;9(8):576-96
references.pmid: 7768349
references.citation: Biol Cell. 2009 May;101(5):251-62
references.pmid: 19275763
references.citation: Nucleic Acids Res. 2010 Jan;38(Database issue):D787-91
references.pmid: 19933260
references.citation: Science. 2002 Dec 6;298(5600):1912-34
references.pmid: 12471243
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):971-9
references.pmid: 16002463
references.citation: Diagn Pathol. 2007 Oct 27;2:41
references.pmid: 17963516
references.citation: Gene. 2004 Apr 14;330:101-14
references.pmid: 15087129
references.citation: Nucleic Acids Res. 2014 Jan;42(Database issue):D472-7
references.pmid: 24243840
references.citation: BMC Syst Biol. 2010 Apr 13;4:43
references.pmid: 20385029
references.citation: Nucleic Acids Res. 2014 Jan;42(Database issue):D199-205
references.pmid: 24214961
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):785-99
references.pmid: 16955069
references.citation: Nat Chem Biol. 2006 Jul;2(7):358-64
references.pmid: 16783341
references.citation: Am Fam Physician. 2008 Feb 1;77(3):311-9
references.pmid: 18297955
references.citation: Curr Med Chem. 2010;17(25):2804-21
references.pmid: 20586715
references.citation: Nat Rev Drug Discov. 2006 Oct;5(10):821-34
references.pmid: 17016423
references.citation: Nat Rev Cancer. 2007 Feb;7(2):79-94
references.pmid: 17251915
references.citation: Cell. 2008 Oct 31;135(3):561-71
references.pmid: 18984166
references.citation: Science. 2014 Jan 3;343(6166):1235681
references.pmid: 24385630
references.citation: Chembiochem. 2011 Aug 16;12(12):1808-12
references.pmid: 21726033
references.citation: J Mol Biol. 1982 May 5;157(1):105-32
references.pmid: 7108955
references.citation: Nat Genet. 2000 May;25(1):25-9
references.pmid: 10802651
references.citation: Genome Biol. 2006;7(6):R45
references.pmid: 16780599
references.citation: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W169-75
references.pmid: 17576678
references.citation: Nature. 2006 Mar 23;440(7083):440-7
references.pmid: 16554803
references.citation: Br J Pharmacol. 2012 Mar;165(6):1670-1677
references.pmid: 21470201
references.citation: Appl Bioinformatics. 2004;3(2-3):105-13
references.pmid: 15693736
references.citation: Drug Discov Ther. 2007 Aug;1(1):23-9
references.pmid: 22504361
references.citation: J Proteome Res. 2006 Nov;5(11):2985-95
references.pmid: 17081050
references.citation: Nucleic Acids Res. 2003 Jan 1;31(1):28-33
references.pmid: 12519941
references.citation: Drug Discov Today. 2005 Dec;10(23-24):1607-10
references.pmid: 16376820
references.citation: Pharmacol Rev. 2006 Jun;58(2):259-79
references.pmid: 16714488
references.citation: Am J Physiol Cell Physiol. 2001 Mar;280(3):C628-36
references.pmid: 11171583
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:1-51
references.pmid: 17009927
references.citation: PLoS One. 2013;8(2):e55484
references.pmid: 23393584
references.citation: Nucleic Acids Res. 2010 Jan;38(Database issue):D142-8
references.pmid: 19843607
references.citation: Science. 2004 Mar 19;303(5665):1800-5
references.pmid: 15031492
references.citation: Nat Rev Drug Discov. 2006 Dec;5(12):993-6
references.pmid: 17139284
references.citation: Proteomics. 2007 Dec;7(23):4255-63
references.pmid: 17963289
references.citation: J Gen Physiol. 2008 May;131(5):395-7
references.pmid: 18411334
references.citation: J Med Chem. 2013 Feb 14;56(3):593-624
references.pmid: 23121096
references.citation: Bioinformatics. 2009 Feb 15;25(4):451-7
references.pmid: 19164304
references.citation: Nat Rev Drug Discov. 2010 Sep;9(9):690-701
references.pmid: 20811381
references.citation: Mol Biosyst. 2010 Aug;6(8):1431-43
references.pmid: 20539873
references.citation: Nat Rev Drug Discov. 2002 Sep;1(9):727-30
references.pmid: 12209152
references.citation: Annu Rev Biochem. 2004;73:1019-49
references.pmid: 15189166
references.citation: Int J Cancer. 2013 Feb 15;132(4):807-12
references.pmid: 22821757
references.citation: Mol Pharmacol. 2003 Jun;63(6):1256-72
references.pmid: 12761335
references.citation: BMC Struct Biol. 2009 Jul 31;9:51
references.pmid: 19646261
references.citation: Nucleic Acids Res. 2012 Jan;40(Database issue):D84-90
references.pmid: 22086963
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41
references.pmid: 21059682
references.citation: ACS Chem Neurosci. 2013 Apr 17;4(4):527-34
references.pmid: 23398684
references.citation: J Physiol. 2007 Jun 1;581(Pt 2):741-55
references.pmid: 17363383
references.citation: Science. 1986 Oct 17;234(4774):364-8
references.pmid: 2876518
references.citation: Science. 2000 Mar 17;287(5460):1960-4
references.pmid: 10720314
references.citation: PLoS Biol. 2006 May;4(5):e144
references.pmid: 16640460
references.citation: Nat Rev Drug Discov. 2002 Mar;1(3):198-210
references.pmid: 12120504
references.citation: Pharmacol Ther. 2002 Feb-Mar;93(2-3):99-111
references.pmid: 12191603
references.citation: Nature. 2005 Dec 15;438(7070):967-74
references.pmid: 16355214
references.citation: Database (Oxford). 2011 Jul 23;2011:bar030
references.pmid: 21785142
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
references.pmid: 18940858